149 related articles for article (PubMed ID: 32807356)
21. Aromatic sialic acid analogues as potential inhibitors of influenza virus neuraminidase.
Bianco A; Brufani M; Melchioni C
Farmaco; 2001 Apr; 56(4):305-9. PubMed ID: 11421259
[TBL] [Abstract][Full Text] [Related]
22. Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses.
Suzuki Y
Biol Pharm Bull; 2005 Mar; 28(3):399-408. PubMed ID: 15744059
[TBL] [Abstract][Full Text] [Related]
23. Heptapeptide ligands against receptor-binding sites of influenza hemagglutinin toward anti-influenza therapy.
Matsubara T; Onishi A; Yamaguchi D; Sato T
Bioorg Med Chem; 2016 Mar; 24(5):1106-14. PubMed ID: 26833245
[TBL] [Abstract][Full Text] [Related]
24. The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en.
Blick TJ; Sahasrabudhe A; McDonald M; Owens IJ; Morley PJ; Fenton RJ; McKimm-Breschkin JL
Virology; 1998 Jun; 246(1):95-103. PubMed ID: 9656997
[TBL] [Abstract][Full Text] [Related]
25. 'Flu' and structure-based drug design.
Wade RC
Structure; 1997 Sep; 5(9):1139-45. PubMed ID: 9331424
[TBL] [Abstract][Full Text] [Related]
26. Neuraminidase activity and specificity of influenza A virus are influenced by haemagglutinin-receptor binding.
Lai JCC; Karunarathna HMTK; Wong HH; Peiris JSM; Nicholls JM
Emerg Microbes Infect; 2019; 8(1):327-338. PubMed ID: 30866786
[TBL] [Abstract][Full Text] [Related]
27. Neuraminidase inhibitors as anti-influenza virus agents.
Kim CU; Chen X; Mendel DB
Antivir Chem Chemother; 1999 Jul; 10(4):141-54. PubMed ID: 10480735
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.
McSharry JJ; McDonough AC; Olson BA; Drusano GL
Clin Diagn Lab Immunol; 2004 Jan; 11(1):21-8. PubMed ID: 14715540
[TBL] [Abstract][Full Text] [Related]
29. Sialyllactose-Modified Three-Way Junction DNA as Binding Inhibitor of Influenza Virus Hemagglutinin.
Yamabe M; Kaihatsu K; Ebara Y
Bioconjug Chem; 2018 May; 29(5):1490-1494. PubMed ID: 29566328
[TBL] [Abstract][Full Text] [Related]
30. Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies.
Ilyushina NA; Komatsu TE; Ince WL; Donaldson EF; Lee N; O'Rear JJ; Donnelly RP
Virol J; 2019 Nov; 16(1):149. PubMed ID: 31783761
[TBL] [Abstract][Full Text] [Related]
31. Chemoenzymatic synthesis of sialyl-α2,3-lactoside-functionalized BSA conjugate inhibits influenza infection.
Xue M; Tan L; Zhang S; Wang JN; Mi X; Si W; Qiao Y; Lao Z; Meng X; Yang Y
Eur J Med Chem; 2024 Jun; 276():116633. PubMed ID: 38968785
[TBL] [Abstract][Full Text] [Related]
32. Recent progress and challenges in the discovery of new neuraminidase inhibitors.
Chamni S; De-Eknamkul W
Expert Opin Ther Pat; 2013 Apr; 23(4):409-23. PubMed ID: 23369206
[TBL] [Abstract][Full Text] [Related]
33. Recent strategies in the search for new anti-influenza therapies.
Wilson JC; von Itzstein M
Curr Drug Targets; 2003 Jul; 4(5):389-408. PubMed ID: 12816348
[TBL] [Abstract][Full Text] [Related]
34. Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity.
Kim JH; Resende R; Wennekes T; Chen HM; Bance N; Buchini S; Watts AG; Pilling P; Streltsov VA; Petric M; Liggins R; Barrett S; McKimm-Breschkin JL; Niikura M; Withers SG
Science; 2013 Apr; 340(6128):71-5. PubMed ID: 23429702
[TBL] [Abstract][Full Text] [Related]
35. Neuraminidase inhibitors as potential anti-influenza drugs.
Bamford MJ
J Enzyme Inhib; 1996; 10(1):1-16. PubMed ID: 8835926
[No Abstract] [Full Text] [Related]
36. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
Choi WS; Jeong JH; Kwon JJ; Ahn SJ; Lloren KKS; Kwon HI; Chae HB; Hwang J; Kim MH; Kim CJ; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046464
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of neuraminidase-resistant sialoside-modified three-way junction DNA and its binding ability to various influenza viruses.
Yamabe M; Fujita A; Kaihatsu K; Ebara Y
Carbohydr Res; 2019 Feb; 474():43-50. PubMed ID: 30711767
[TBL] [Abstract][Full Text] [Related]
38. Divalent oseltamivir analogues as potent influenza neuraminidase inhibitors.
Yan ZL; Liu AY; Wei XX; Zhang Z; Qin L; Yu Q; Yu P; Lu K; Yang Y
Carbohydr Res; 2019 May; 477():32-38. PubMed ID: 30954773
[TBL] [Abstract][Full Text] [Related]
39. Monomeric inhibitors of influenza neuraminidase enhance the hemagglutination inhibition activities of polyacrylamides presenting multiple C-sialoside groups.
Choi SK; Mammen M; Whitesides GM
Chem Biol; 1996 Feb; 3(2):97-104. PubMed ID: 8807834
[TBL] [Abstract][Full Text] [Related]
40. A Zanamivir-protein conjugate mimicking mucin for trapping influenza virion particles and inhibiting neuraminidase activity.
Xue M; Deng A; Wang JN; Mi X; Lao Z; Yang Y
Int J Biol Macromol; 2024 Jun; 275(Pt 1):133564. PubMed ID: 38955298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
